التفاصيل البيبلوغرافية
| العنوان: |
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. |
| المؤلفون: |
Testori A, Richards J, Whitman E, Mann GB, Lutzky J, Camacho L, Parmiani G, Tosti G, Kirkwood JM, Hoos A, Yuh L, Gupta R, Srivastava PK, C-100-21 Study Group, Testori, Alessandro, Richards, Jon, Whitman, Eric, Mann, G Bruce, Lutzky, Jose, Camacho, Luis |
| المصدر: |
Journal of Clinical Oncology; 2/20/2008, Vol. 26 Issue 6, p955-962, 8p |
| قاعدة البيانات: |
Supplemental Index |
